These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36481224)

  • 21. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity.
    Faeh D; William J; Yerly P; Paccaud F; Bovet P
    Cardiovasc Diabetol; 2007 Oct; 6():32. PubMed ID: 17958881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.
    Bancks MP; Carson AP; Lewis CE; Gunderson EP; Reis JP; Schreiner PJ; Yano Y; Carnethon MR
    Diabetologia; 2019 Aug; 62(8):1366-1374. PubMed ID: 31115643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.
    Nyström T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
    Diabetes Obes Metab; 2017 Jun; 19(6):831-841. PubMed ID: 28116795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversion From Pre-Diabetes Mellitus to Normoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in a Chinese Population: A Prospective Cohort Study.
    Liu X; Wu S; Song Q; Wang X
    J Am Heart Assoc; 2021 Feb; 10(3):e019045. PubMed ID: 33496188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.
    Mori Y; Hoshino K; Yokota K; Yokose T; Tajima N
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):334-9. PubMed ID: 15977101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.
    Uusitupa M; Peltonen M; Lindström J; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Valle TT; Eriksson JG; Tuomilehto J;
    PLoS One; 2009 May; 4(5):e5656. PubMed ID: 19479072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting Plasma Insulin at 5 Years of Age Predicted Subsequent Weight Increase in Early Childhood over a 5-Year Period-The Da Qing Children Cohort Study.
    Chen YY; Wang JP; Jiang YY; Li H; Hu YH; Lee KO; Li GW
    PLoS One; 2015; 10(6):e0127389. PubMed ID: 26047327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report.
    Tsuchida K; Mitsuma W; Sato Y; Ozaki K; Soda S; Hatada K; Tanaka K; Hosaka Y; Imai S; Takahashi K; Matsubara T; Oda H
    Acta Diabetol; 2020 Feb; 57(2):173-182. PubMed ID: 31375898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
    Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
    JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).
    Rubins HB; Robins SJ; Collins D; Nelson DB; Elam MB; Schaefer EJ; Faas FH; Anderson JW
    Arch Intern Med; 2002 Dec 9-23; 162(22):2597-604. PubMed ID: 12456232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.
    Piché ME; Lemieux S; Pérusse L; Weisnagel SJ
    Diabetologia; 2005 Apr; 48(4):732-40. PubMed ID: 15765221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.
    Perseghin G; Calori G; Lattuada G; Ragogna F; Dugnani E; Garancini MP; Crosignani P; Villa M; Bosi E; Ruotolo G; Piemonti L
    Acta Diabetol; 2012 Dec; 49(6):421-8. PubMed ID: 22215126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
    Wang T; Li M; Zeng T; Hu R; Xu Y; Xu M; Zhao Z; Chen Y; Wang S; Lin H; Yu X; Chen G; Su Q; Mu Y; Chen L; Tang X; Yan L; Qin G; Wan Q; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Shi L; Ning G; Bi Y; Wang W; Lu J
    Diabetes Care; 2022 Aug; 45(8):1863-1872. PubMed ID: 35700159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of ankle-brachial index and blood glucose on the outcomes of six-year all-cause mortality and cardiovascular mortality in a Chinese population of type 2 diabetes patients.
    Wang Y; Mou Q; Zhao D; Xu Y; Hu D; Ma H; Liu J; Guo X; Li J
    Int Angiol; 2012 Dec; 31(6):586-94. PubMed ID: 23222938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired glucose tolerance predicts all-cause mortality among older men at high risk for cardiovascular disease in China.
    Fang F; Wang N; Yan S; Wang L; Lu Y; Li J; Li H; Pham G; Li C; Leng SX; Tian H
    Prim Care Diabetes; 2019 Dec; 13(6):495-504. PubMed ID: 30862424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of 10-year mortality using hs-CRP in Chinese people with hyperglycemia: Findings from the Da Qing diabetes prevention outcomes study.
    Qian X; He S; Wang J; Gong Q; An Y; Li H; Chen Y; Li G
    Diabetes Res Clin Pract; 2021 Mar; 173():108668. PubMed ID: 33453295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study.
    Lowe LP; Liu K; Greenland P; Metzger BE; Dyer AR; Stamler J
    Diabetes Care; 1997 Feb; 20(2):163-9. PubMed ID: 9118765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.